Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Resistance to HSP90 inhibition involving loss of MCL1 addiction.

S Busacca | E W P Law | I R Powley | D A Proia | M Sequeira | J Le Quesne | A Klabatsa | J M Edwards | K B Matchett | J L Luo | J H Pringle | M El-Tanani | M MacFarlane | D A Fennell
Oncogene | 2016

Inhibition of the chaperone heat-shock protein 90 (HSP90) induces apoptosis, and it is a promising anti-cancer strategy. The mechanisms underpinning apoptosis activation following HSP90 inhibition and how they are modified during acquired drug resistance are unknown. We show for the first time that, to induce apoptosis, HSP90 inhibition requires the cooperation of multi BH3-only proteins (BID, BIK, PUMA) and the reciprocal suppression of the pro-survival BCL-2 family member MCL1, which occurs via inhibition of STAT5A. A subset of tumour cell lines exhibit dependence on MCL1 expression for survival and this dependence is also associated with tumour response to HSP90 inhibition. In the acquired resistance setting, MCL1 suppression in response to HSP90 inhibitors is maintained; however, a switch in MCL1 dependence occurs. This can be exploited by the BH3 peptidomimetic ABT737, through non-BCL-2-dependent synthetic lethality.

Pubmed ID: 26096930

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_14117
  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_15045
  • Agency: Medical Research Council, United Kingdom
    Id: MC_U132685863
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UP_1203/1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PUMA (tool)

RRID:SCR_002057

Software program for developing probabilistic models for the analysis of microarray data.

View all literature mentions

Applied Biosystems (tool)

RRID:SCR_005039

An Antibody supplier

View all literature mentions

Abcam HEK293T MCL1 KO (tool)

RRID:CVCL_B3AW

Cell line Abcam HEK293T MCL1 KO is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NCI-H460 (tool)

RRID:CVCL_0459

Cell line NCI-H460 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NCI-H1299 (tool)

RRID:CVCL_0060

Cell line NCI-H1299 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions